omega-n-methylarginine has been researched along with Cardiovascular Stroke in 17 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 6 (35.29) | 18.2507 |
2000's | 9 (52.94) | 29.6817 |
2010's | 2 (11.76) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arós, F; Clish, CB; Corella, D; Estruch, R; Fitó, M; Gómez-Gracia, E; Guasch-Ferré, M; Hruby, A; Hu, FB; Lapetra, J; Liang, L; Martínez-González, MA; Romaguera, D; Ros, E; Ruiz-Canela, M; Salas-Salvadó, J; Serra-Majem, L; Toledo, E; Wang, DD; Yu, E | 1 |
Gonon, AT; Kiss, A; Pernow, J; Sjöquist, PO; Tratsiakovich, Y; Yang, J | 1 |
Genda, S; Ichikawa, Y; Miki, T; Miura, T; Shimamoto, K | 1 |
Hirooka, Y; Kimura, Y; Kishi, T; Shigematsu, H; Takeshita, A; Ueta, Y | 1 |
Hirooka, Y; Ito, K; Kishi, T; Sakai, K; Shigematsu, H; Shimokawa, H; Sunagawa, K; Takeshita, A | 1 |
Alexander, JH; Baran, DA; Buller, CE; Cantor, WJ; Cotter, G; Dzavík, V; Farkouh, ME; Gross, SS; Harrington, RA; Hathaway, D; Hazen, SL; Hochman, JS; Holmes, DR; Kleiman, NS; Ohman, EM; Panza, JA; Parrillo, JE; Prondzinsky, R; Ramanathan, K; Reynolds, HR; Stebbins, AL; Vered, Z; Webb, JG | 1 |
Baker, JE; Fu, X; Gross, GJ; Hsu, A; Strande, JL; Su, J | 1 |
Higasa, S; Kakishita, E; Oku, KI; Seto, T; Suehiro, A; Yoshimoto, H | 1 |
Carmines, PK; Didion, SP; Ikenaga, H; Mayhan, WG | 1 |
Baron, AD; Fei, L; Henry, DP; Zipes, DP | 1 |
Doi, H; Kawano, H; Kugiyama, K; Matsumura, T; Misumi, K; Motoyama, T; Nakagawa, O; Nakajima, K; Nakano, T; Ogawa, H; Soejima, H; Sugiyama, S; Yasue, H; Yoshimura, M | 1 |
Buikema, H; Crijns, HJ; de Zeeuw, D; Monnink, SH; Tio, RA; van Gilst, WH | 1 |
Hasegawa, T; Kuno, A; Miki, T; Miura, T; Nakano, A; Shimamoto, K; Tsuchida, A | 1 |
Boulanger, CM; Ebrahimian, T; Henry, P; Mallat, Z; Mathieu, E; Scoazec, A; Tedgui, A | 1 |
Hasegawa, T; Kuno, A; Miki, T; Miura, T; Nishino, Y; Shimamoto, K; Tsuchida, A | 1 |
Christes, A; Drexler, H; Hablawetz, E; Lu, W; Riede, U | 1 |
Drexler, H; Lu, W | 1 |
1 trial(s) available for omega-n-methylarginine and Cardiovascular Stroke
Article | Year |
---|---|
Effect of nitric oxide synthase inhibition on haemodynamics and outcome of patients with persistent cardiogenic shock complicating acute myocardial infarction: a phase II dose-ranging study.
Topics: Aged; Enzyme Inhibitors; Female; Hemodynamics; Humans; Infusions, Intravenous; Male; Myocardial Infarction; Nitric Oxide Synthase; omega-N-Methylarginine; Shock, Cardiogenic | 2007 |
16 other study(ies) available for omega-n-methylarginine and Cardiovascular Stroke
Article | Year |
---|---|
Plasma Arginine/Asymmetric Dimethylarginine Ratio and Incidence of Cardiovascular Events: A Case-Cohort Study.
Topics: Aged; Arginine; Cardiovascular Diseases; Case-Control Studies; Chromatography, Liquid; Citrulline; Cohort Studies; Female; Humans; Incidence; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; omega-N-Methylarginine; Ornithine; Proportional Hazards Models; Prospective Studies; Risk Factors; Stroke; Tandem Mass Spectrometry | 2017 |
Inhibition of Rho kinase protects from ischaemia-reperfusion injury via regulation of arginase activity and nitric oxide synthase in type 1 diabetes.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Arginase; Arginine; Cytoprotection; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide Synthase; omega-N-Methylarginine; Protein Kinase Inhibitors; Rats, Sprague-Dawley; rho GTP-Binding Proteins; rho-Associated Kinases; Signal Transduction | 2017 |
K(ATP) channel opening is an endogenous mechanism of protection against the no-reflow phenomenon but its function is compromised by hypercholesterolemia.
Topics: Adenosine Triphosphate; Analysis of Variance; Animals; Chronic Disease; Coronary Circulation; Disease Models, Animal; Glyburide; Hemodynamics; Hypercholesterolemia; Male; Myocardial Infarction; Nicorandil; Nitric Oxide Synthase; omega-N-Methylarginine; Potassium Channel Blockers; Potassium Channels; Rabbits; Vasodilator Agents | 2002 |
Reduced nitric oxide synthase in the brainstem contributes to enhanced sympathetic drive in rats with heart failure.
Topics: Animals; Blood Pressure; Blotting, Western; Brain Stem; Disease Models, Animal; Echocardiography; Gene Expression; Heart Failure; Hemodynamics; In Situ Hybridization; Injections, Intraventricular; Male; Myocardial Infarction; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Norepinephrine; omega-N-Methylarginine; Organ Size; Rats; Rats, Inbred WKY; RNA, Messenger; Solitary Nucleus; Sympathetic Nervous System | 2003 |
Overexpression of eNOS in brain stem reduces enhanced sympathetic drive in mice with myocardial infarction.
Topics: Adenoviridae; Animals; beta-Galactosidase; Blood Pressure; Blotting, Western; Brain Stem; Coronary Vessels; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Gene Transfer Techniques; Heart Rate; Immunohistochemistry; Male; Mice; Myocardial Infarction; Nitric Oxide; Norepinephrine; omega-N-Methylarginine; Solitary Nucleus; Sympathetic Nervous System; Ventricular Function, Left | 2005 |
SCH 79797, a selective PAR1 antagonist, limits myocardial ischemia/reperfusion injury in rat hearts.
Topics: Androstadienes; Animals; Cardiotonic Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Glyburide; Hirudins; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide; Nitric Oxide Synthase; Oligopeptides; omega-N-Methylarginine; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Potassium Channel Blockers; Potassium Channels; Proto-Oncogene Proteins c-akt; Pyrroles; Quinazolines; Rats; Rats, Sprague-Dawley; Receptor, PAR-1; Recombinant Proteins; Research Design; RNA, Messenger; Signal Transduction; Thrombin; Time Factors; Ventricular Function, Left; Wortmannin | 2007 |
[Inhibitory effect of isosorbide dinitrate on whole blood aggregation].
Topics: Angina Pectoris; Blood; Cell Aggregation; Cyclic GMP; Female; Humans; In Vitro Techniques; Isosorbide Dinitrate; Leukocytes; Male; Methylene Blue; Middle Aged; Myocardial Infarction; omega-N-Methylarginine; Platelet Aggregation; Platelet Aggregation Inhibitors; Vasodilator Agents | 1997 |
Enhanced constrictor responses of skeletal muscle arterioles during chronic myocardial infarction.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Angiotensin II; Animals; Arginine Vasopressin; Arterioles; Coronary Vessels; Endothelin-1; Hemodynamics; Male; Muscle, Skeletal; Muscle, Smooth, Vascular; Myocardial Infarction; omega-N-Methylarginine; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Sprague-Dawley; Reference Values; Thromboxane A2; Time Factors; Vasoconstriction; Vasoconstrictor Agents | 1997 |
Intrapericardial delivery of L-arginine reduces the increased severity of ventricular arrhythmias during sympathetic stimulation in dogs with acute coronary occlusion: nitric oxide modulates sympathetic effects on ventricular electrophysiological properti
Topics: Animals; Arginine; Confounding Factors, Epidemiologic; Disease Models, Animal; Dogs; Electric Stimulation; Enzyme Inhibitors; Myocardial Contraction; Myocardial Infarction; Nitric Oxide; Nitric Oxide Synthase; Norepinephrine; omega-N-Methylarginine; Pericardium; Severity of Illness Index; Tachycardia, Ventricular | 1997 |
Association of remnant lipoprotein levels with impairment of endothelium-dependent vasomotor function in human coronary arteries.
Topics: Acetylcholine; Adult; Aged; Coronary Angiography; Coronary Circulation; Coronary Disease; Endothelium, Vascular; Enzyme Inhibitors; Female; Humans; Lipoproteins; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; omega-N-Methylarginine; Risk Factors | 1998 |
Comparison of zofenopril and lisinopril to study the role of the sulfhydryl-group in improvement of endothelial dysfunction with ACE-inhibitors in experimental heart failure.
Topics: Acetylcholine; Acetylcysteine; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Blood Pressure; Body Weight; Calcimycin; Captopril; Endothelium, Vascular; Heart Diseases; In Vitro Techniques; Lisinopril; Male; Myocardial Infarction; Nitrates; Nitrites; Nitroglycerin; omega-N-Methylarginine; Rats; Rats, Wistar; Sodium Nitrite; Sulfhydryl Compounds; Vasodilation; Vasodilator Agents | 2000 |
Endothelium-dependent coronary response is impaired in the myocardium at an early phase of post-infarct remodeling.
Topics: Acetylcholine; Animals; Coronary Circulation; Coronary Vessels; Endothelium; Heart Rate; In Vitro Techniques; Male; Myocardial Infarction; Myocardium; Nitroprusside; omega-N-Methylarginine; Rabbits; Ventricular Pressure; Ventricular Remodeling | 2000 |
Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction.
Topics: Adult; Animals; Aorta; Cell Membrane; Cell Membrane Structures; Cyclooxygenase Inhibitors; Diclofenac; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Female; Humans; In Vitro Techniques; Ionophores; Male; Middle Aged; Myocardial Infarction; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Particle Size; Rats; Rats, Wistar; Vasoconstrictor Agents; Vasodilator Agents; Vasomotor System | 2001 |
Blockade of angiotensin II type 1 receptors suppressed free radical production and preserved coronary endothelial function in the rabbit heart after myocardial infarction.
Topics: Acetylcholine; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Endothelium, Vascular; Enzyme Inhibitors; Free Radicals; Hemodynamics; In Vitro Techniques; Lipid Peroxides; Male; Myocardial Infarction; Myocardium; Nitroprusside; omega-N-Methylarginine; Oxygen; Rabbits; Receptor, Angiotensin, Type 1; Tetrazoles; Tiopronin; Valine; Valsartan; Vasodilator Agents; Ventricular Remodeling | 2002 |
Effects of inhibition of nitric oxide formation on regional blood flow in experimental myocardial infarction.
Topics: Animals; Arginine; Blood Pressure; Coronary Circulation; Dipyridamole; Hemodynamics; Male; Myocardial Infarction; Nitric Oxide; Nitroglycerin; omega-N-Methylarginine; Rats; Rats, Inbred Strains; Time Factors; Vascular Resistance | 1992 |
Endothelial dysfunction of hindquarter resistance vessels in experimental heart failure.
Topics: Acetylcholine; Animals; Arginine; Blood Vessels; Cardiac Output, Low; Chronic Disease; Dose-Response Relationship, Drug; Endothelium, Vascular; Hindlimb; Male; Myocardial Infarction; Nitroglycerin; omega-N-Methylarginine; Rats; Rats, Inbred Strains; Vascular Resistance | 1992 |